Ameritas Investment Partners’s Antares Pharma, Inc. ATRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-14,209
| Closed | -$58K | – | 3363 |
|
|
2022
Q1 | $58K | Hold |
14,209
| – | – | ﹤0.01% | 1984 |
|
|
2021
Q4 | $51K | Hold |
14,209
| – | – | ﹤0.01% | 2126 |
|
|
2021
Q3 | $52K | Hold |
14,209
| – | – | ﹤0.01% | 2132 |
|
|
2021
Q2 | $62K | Hold |
14,209
| – | – | ﹤0.01% | 2053 |
|
|
2021
Q1 | $58K | Hold |
14,209
| – | – | ﹤0.01% | 1997 |
|
|
2020
Q4 | $57K | Hold |
14,209
| – | – | ﹤0.01% | 1907 |
|
|
2020
Q3 | $38K | Hold |
14,209
| – | – | ﹤0.01% | 2018 |
|
|
2020
Q2 | $39K | Hold |
14,209
| – | – | ﹤0.01% | 1991 |
|
|
2020
Q1 | $34K | Hold |
14,209
| – | – | ﹤0.01% | 1886 |
|
|
2019
Q4 | $67K | Buy |
14,209
+1,597
| +13% | +$6.54K | ﹤0.01% | 1745 |
|
|
2019
Q3 | $42K | Hold |
12,612
| – | – | ﹤0.01% | 1996 |
|
|
2019
Q2 | $41K | Hold |
12,612
| – | – | ﹤0.01% | 2031 |
|
|
2019
Q1 | $38K | Hold |
12,612
| – | – | ﹤0.01% | 2045 |
|
|
2018
Q4 | $34K | Hold |
12,612
| – | – | ﹤0.01% | 2034 |
|
|
2018
Q3 | $42K | Hold |
12,612
| – | – | ﹤0.01% | 2092 |
|
|
2018
Q2 | $33K | Hold |
12,612
| – | – | ﹤0.01% | 2240 |
|
|
2018
Q1 | $28K | Hold |
12,612
| – | – | ﹤0.01% | 2252 |
|
|
2017
Q4 | $25K | Hold |
12,612
| – | – | ﹤0.01% | 2342 |
|
|
2017
Q3 | $37K | Hold |
12,612
| – | – | ﹤0.01% | 2070 |
|
|
2017
Q2 | $41K | Buy |
+12,612
| New | +$35.7K | ﹤0.01% | 2044 |
|
Other funds holding ATRS
Ameritas Investment Partners's ATRS Position: Q2 2022 in Review
Ameritas Investment Partners sold out of Antares Pharma, Inc. (ATRS) in Q2 2022, closing a stake of 14,209 shares — an estimated $58K sold.
Ameritas Investment Partners first reported a position in ATRS in Q2 2017 and held it in 20 quarters. The position peaked at $67K in Q4 2019. 1 fund tracked by Wall St. Rank holds ATRS as of Q2 2022.
- Ameritas Investment Partners reported no remaining Antares Pharma, Inc. position as of Q2 2022 after selling out during the quarter.
- Ameritas Investment Partners sold 14,209 Antares Pharma, Inc. shares in Q2 2022, an estimated $58K.
- Ameritas Investment Partners first reported a position in Antares Pharma, Inc. in Q2 2017 and held it in 20 quarters.
- Ameritas Investment Partners's Antares Pharma, Inc. position peaked at $67K in Q4 2019.
- 1 fund tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2022.
Based on Ameritas Investment Partners's 13F filing for Q2 2022, filed 12 Aug 2022.